Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism MAO-A inhibitors(Monoamine oxidase A inhibitors), MAO-B inhibitors(Monoamine oxidase B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H27BrFN3O3 |
InChIKeyQXKZTLAPDSJMIX-BQAIUKQQSA-N |
CAS Registry3057204-28-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Staphylococcus Aureus Infections | Preclinical | China | 04 Jul 2025 | |
| Staphylococcus Aureus Infections | Preclinical | China | 04 Jul 2025 |





